XML 77 R54.htm IDEA: XBRL DOCUMENT v3.10.0.1
Revenue from Contracts with Customers - Additional Information (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Disaggregation Of Revenue [Line Items]          
Agreements for product and product-related services revenue 1 year   1 year    
Agreements for product and product-related services revenue, description     The Company’s agreements for product and product-related services revenue have an expected duration of one year or less    
Revenue $ 4,706,378 $ 3,723,484 $ 13,775,796 $ 6,855,409  
Contract liabilities 387,975   387,975   $ 837,885
Cumulative catch up adjustment 0   30,055    
Collaborative Development Services          
Disaggregation Of Revenue [Line Items]          
Revenue 3,391,534 2,130,694 $ 8,704,094 2,433,105  
Contract liabilities         110,317
Bristol Myers Squibb          
Disaggregation Of Revenue [Line Items]          
Agreement expiration date     May 11, 2019    
Number of days material breach remains uncured     60 days    
Agreement termination notice period     90 days    
Revenue 166,714 31,250 $ 298,938 93,750  
Contract liabilities 79,918   79,918   $ 160,106
Partially unsatisfied performance obligation aggregate amount 50,000   50,000    
Merck KGaA Agreement | Collaborative Development Services          
Disaggregation Of Revenue [Line Items]          
Revenue $ 0 0 $ 0 25,000  
Additional milestone payment earned   $ 0   $ 0  
Minimum          
Disaggregation Of Revenue [Line Items]          
Customer payment term     30 days    
Maximum          
Disaggregation Of Revenue [Line Items]          
Customer payment term     90 days